GLA

gene product
GALA
This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
252 antibodies from 30 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
antibodies-online
72 antibodies
GeneTex
5 antibodies
Abgent
1 antibody
Invitrogen Antibodies
5 antibodies
NovoPro Bioscience Inc.
3 antibodies
Novus Biologicals
8 antibodies
Acris Antibodies GmbH
4 antibodies
Atlas Antibodies
2 antibodies
LifeSpan BioSciences, Inc.
67 antibodies
Proteintech Group
3 antibodies
ProSci
2 antibodies
Biorbyt
11 antibodies
St John's Laboratory
2 antibodies
Bioworld Technology, Inc
1 antibody
Abnova Corporation
4 antibodies
OriGene
2 antibodies
Aviva Systems Biology
2 antibodies
Abbexa
4 antibodies
MyBioSource
5 antibodies
Sino Biological Inc.
5 antibodies
RabMAbs
3 antibodies
Creative Biolabs
5 antibodies
United States Biological
13 antibodies
Creative Diagnostics
4 antibodies
NSJ Bioreagents
1 antibody
R&D Systems
1 antibody
Sigma-Aldrich
3 antibodies
EMD Millipore
1 antibody
RayBiotech, Inc.
1 antibody